Stocks

DexCom Rises 2.39% to $83.34, Extending Weekly Gain to Nearly 5%

Shares of the continuous glucose monitor maker climbed for a second consecutive session, pushing the stock's seven-day advance to 4.96%.

By Love Wallet · November 14, 2026

DexCom Rises 2.39% to $83.34, Extending Weekly Gain to Nearly 5%
Price
$83.34
24h
+2.39%
1 week
+4.96%
1 month
-0.18%
Market cap
$30.35B

DexCom, Inc. (DXCM) closed at $83.34 on November 14, 2026, a gain of 2.39% on the session. The move added to a strong week for the medical device company, which has now advanced 4.96% over the past seven days.

Despite the recent momentum, the stock remains nearly flat on a longer time horizon, posting a 30-day change of -0.18%. That marginal decline suggests the latest gains have largely recovered ground lost earlier in the month.

DexCom's market capitalization stood at $30.35 billion as of the close, reflecting the company's standing as a major player in the diabetes technology sector. The stock's near-term trajectory has turned positive even as the broader 30-day performance remains essentially unchanged.

Market data is provided for informational purposes only and may be delayed. Nothing in this article is financial advice.

Track DexCom, Inc. and your whole portfolio with Love Wallet.

Get started free